MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/03/6401-11-20$20.00
Mol Pharmacol 64:11-20, 2003

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elenko, E.
Right arrow Articles by Farquhar, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elenko, E.
Right arrow Articles by Farquhar, M. G.

Spatial Regulation of G{alpha}i Protein Signaling in Clathrin-Coated Membrane Microdomains Containing GAIP

Eric Elenko, Thierry Fischer, Ingrid Niesman, Tim Harding, Tammie McQuistan, Mark Von Zastrow, and Marilyn G. Farquhar

Departments of Cellular and Molecular Medicine (E.E., T.F., I.N., T.H., T.M., M.G.F.) and Pathology (T.H., M.G.F.), University of California San Diego, La Jolla, California; and Department of Psychiatry, University of California San Francisco, San Francisco, California

Regulators of G-protein signaling (RGS) proteins are GTPase-activating proteins (GAPs) that bind to G{alpha} subunits and attenuate G protein signaling, but where these events occur in the cell is not yet established. Here we investigated, by immunofluorescence labeling and deconvolution analysis, the site at which endogenous G{alpha}-interacting protein (GAIP) (RGS19) binds to G{alpha}i3-YFP and its fate after activation of {delta}-opioid receptor (DOR). In the absence of agonist, GAIP is spatially segregated from G{alpha}i3 and DOR in clathrin-coated domains (CCPs) of the cell membrane (PM), whereas G{alpha}i3-YPF and DOR are located in non–clathrin-coated microdomains of the PM. Upon addition of agonist, G{alpha}i3 partially colocalizes with GAIP in CCPs at the PM. When endocytosis is blocked by expression of a dynamin mutant [dyn(K44A)], there is a striking overlap in the distribution of DOR and G{alpha}i3-YFP with GAIP in CCPs. Moreover, G{alpha}i3-YFP and GAIP form a coprecipitable complex. Our results support a model whereby, after agonist addition, DOR and G{alpha}i3 move together into CCPs where G{alpha}i3 and GAIP meet and turn off G protein signaling. Subsequently, G{alpha}i3 returns to non–clathrin-coated microdomains of the PM, GAIP remains stably associated with CCPs, and DOR is internalized via clathrin-coated vesicles. This constitutes a novel mechanism for regulation of G{alpha} signaling through spatial segregation of a GAP in clathrin-coated pits.


Received August 2, 2002; accepted March 21, 2003

Address correspondence to: Dr. Marilyn G. Farquhar, Department of Cellular and Molecular Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA, 92093-0651. E-mail: mfarquhar{at}ucsd.edu




This article has been cited by other articles:


Home page
Biophys. JHome page
M. R. Maurya and S. Subramaniam
A Kinetic Model for Calcium Dynamics in RAW 264.7 Cells: 1. Mechanisms, Parameters, and Subpopulational Variability
Biophys. J., August 1, 2007; 93(3): 709 - 728.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. Varsano, M.-Q. Dong, I. Niesman, H. Gacula, X. Lou, T. Ma, J. R. Testa, J. R. Yates III, and M. G. Farquhar
GIPC Is Recruited by APPL to Peripheral TrkA Endosomes and Regulates TrkA Trafficking and Signaling
Mol. Cell. Biol., December 1, 2006; 26(23): 8942 - 8952.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Le-Niculescu, I. Niesman, T. Fischer, L. DeVries, and M. G. Farquhar
Identification and Characterization of GIV, a Novel G{alpha}i/s -interacting Protein Found on COPI, Endoplasmic Reticulum-Golgi Transport Vesicles
J. Biol. Chem., June 10, 2005; 280(23): 22012 - 22020.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
G.-x. Xie and P. P. Palmer
RGS Proteins: New Players in the Field of Opioid Signaling and Tolerance Mechanisms
Anesth. Analg., April 1, 2005; 100(4): 1034 - 1042.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. Pineyro, M. Azzi, A. deLean, P. W. Schiller, and M. Bouvier
Reciprocal Regulation of Agonist and Inverse Agonist Signaling Efficacy upon Short-Term Treatment of the Human {delta}-Opioid Receptor with an Inverse Agonist
Mol. Pharmacol., January 1, 2005; 67(1): 336 - 348.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. J. Bornheimer, M. R. Maurya, M. G. Farquhar, and S. Subramaniam
Computational modeling reveals how interplay between components of a GTPase-cycle module regulates signal transduction
PNAS, November 9, 2004; 101(45): 15899 - 15904.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
F. Jeanneteau, O. Guillin, J. Diaz, N. Griffon, and P. Sokoloff
GIPC Recruits GAIP (RGS19) To Attenuate Dopamine D2 Receptor Signaling
Mol. Biol. Cell, November 1, 2004; 15(11): 4926 - 4937.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics